Trailing-twelve-month (TTM) revenue is $38.33 Billion with a year-over-year growth of +4.48%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q4 FY2025Period ended 2025-09-28 | $9,569,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-14 |
| Q1 FY2026Period ended 2025-12-28 | $9,908,400,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-01-28 |
| Q2 FY2026Period ended 2026-03-29 | $9,531,500,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-28 |
| Q3 FY2026Period ended 2026-06-28 | $9,322,700,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-29 |
| TTM revenue | $38,331,600,000 |
Current P/S: $112,563,600,000 market capitalization ÷ $38,331,600,000 TTM revenue = 2.94x.
Market capitalization source: FMP quote. Quote observed 2026-09-11T20:00:00.000Z. Latest revenue period ended 2026-06-28.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q3 FY2026 (2026-06-28): $9.32B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-12T00:05:54.226Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-09-28 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-09-28 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-09-27 · USD | FY20212021-10-03 · USD | FY20222022-10-02 · USD | FY20232023-10-01 · USD | FY20242024-09-29 · USD | FY20252025-09-28 · USD |
|---|---|---|---|---|---|---|
| Beverage Member | $14.3B | $18.3B | $19.6B | $21.7B | $21.9B | $22.5B |
| Food Member | $3.8B | $5.1B | $5.8B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-09-27 · USD | FY20212021-10-03 · USD | FY20222022-10-02 · USD | FY20232023-10-01 · USD | FY20242024-09-29 · USD | FY20252025-09-28 · USD |
|---|---|---|---|---|---|---|
| CHINA | $2.6B | $3.7B | $3.0B | $3.1B | $3.0B | $3.2B |
| International Segment | $4.1B | $5.0B | $5.9B | $6.5B |
$38.33B
$38.33 Billion
+4.48%
vs. $36.69B a year ago (TTM)
+7.16%
5 Year compound annual growth rate
1 Year
+4.48%
3 Year
+3.77%
5 Year
+7.16%
10 Year
+6.45%
15 Year
+8.42%
20 Year
+8.70%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $37.18B | +$1.01B | +2.79% |
| 2024 | $36.18B | +$200.60M | +0.56% |
| 2023 | $35.98B | +$3.73B | +11.55% |
| 2022 | $32.25B | +$3.19B | +10.98% |
| 2021 | $29.06B | +$5.54B | +23.57% |
| 2020 |
TTM Growth
+4.48%
3-Year CAGR
+3.77%
5-Year CAGR
+7.16%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-12T00:05:54.226Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $6.7B |
| $7.0B |
| Other Products Member | $5.4B | $5.7B | $6.9B | $7.7B | $7.5B | $7.6B |
|---|
| $6.5B |
| $6.9B |
| UNITED STATES | $16.9B | $20.4B | $23.4B | $26.4B | $26.7B | $27.1B |
|---|
| $23.52B |
| ($2.99B) |
| (11.28%) |
| 2019 | $26.51B | +$1.79B | +7.24% |
| 2018 | $24.72B | +$2.33B | +10.42% |
| 2017 | $22.39B | +$1.07B | +5.02% |
| 2016 | $21.32B | +$2.15B | +11.24% |
